NPHub offers the most advanced marketplace in the healthcare industry, connecting Nurse Practitioner (NP) students with preceptors nationwide for clinical placements. As an Inc 5000 company, NPHub stands out for its rapid placement capabilities, specialized mobile app for NP preceptors, and strong relationships with universities and providers.
As in previous years, Venture Atlanta 2023 is anticipated to be a sold-out event, with over 1,400 entrepreneurs, founders, investors, and business leaders expected to be in attendance.
“Venture Atlanta 2023 continues to bring attendees all the events they love, including informative panels, big-name keynotes, and networking opportunities,” said Venture Atlanta CEO Allyson Eman. “This year, we’ve also reimagined our schedule to give more stage time to promising tech companies and centered even more of our programming around fostering connections.”
Venture Atlanta boasts a roster of highly successful alumni, including Bitcoin Depot, CallRail, Car360, Clearleap, Flock Safety, Florence Healthcare, Kabbage, ParkMobile, Pindrop Security, Salesforce Pardot, Salesloft, SingleOps, Stax, and Terminus.
To learn more about NPHub, visit [INSERT URL]. For additional information about Venture Atlanta, to register for the event, or to view the conference schedule, please visit www.ventureatlanta.org.
About Venture Atlanta Venture Atlanta, the Southeast’s technology innovation event, is where the region’s most promising tech companies meet the country’s top-tier investors. As the Southeast’s largest investor showcase helping launch more than 760 companies and raise $7.5 billion in funding to date, the event connects the region’s top entrepreneurs with local and national investors and others in the technology ecosystem who can help them raise the capital they need to grow their businesses. The annual nonprofit event is a collaboration of the Atlanta CEO Council, Metro Atlanta Chamber, and the Technology Association of Georgia (TAG). For more information, visit www.ventureatlanta.org. For updates, follow us on Twitter and LinkedIn, and visit our blog.
About NPHub NPHub is an Inc 5000 recognized healthcare technology company specializing in connecting graduate nursing students with experienced Nurse Practitioner (NP) preceptors across the United States. Founded in 2017 and headquartered in Atlanta, NPHub has revolutionized the clinical rotation placement process through its advanced web and mobile platforms. The company targets NP students struggling to find clinical rotations and NP preceptors looking to be compensated for their expertise. As the leader in the sector, NPHub takes pride in its rapid placement capabilities and strong relationships with universities, clinics, and healthcare professionals nationwide.
Down payment grants made possible through insurer’s membership with the Federal Home Loan Bank of Des Moines EAGAN, Minn. and SAINT PAUL, Minn., Aug. 31, 2023 /PRNewswire/ — Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced it has access to $160,000 in Affordable…
Marketing veteran will lead marketing initiatives at Amare Global to deepen brand identity, improve Brand Partner experience, and continue to amplify Amare’s mental wellness mission.
LEHI, Utah, Aug. 31, 2023 /PRNewswire-PRWeb/ — Amare Global, The Mental Wellness Company® and leader in all-natural, innovative mental wellness solutions, is pleased to announce the promotion of Andrea Neipp to Chief Marketing Officer (CMO), from her previous role at the company as Executive Vice President (EVP) of Global Marketing. Andrea will continue to oversee the global marketing organization with responsibility for building the brand, providing exceptional marketing tools to field leaders, and driving customer demand in Amare’s 50 markets around the world in this next phase of Amare’s growth.
“As The Mental Wellness Company, our mission at Amare is to create a global mental wellness movement that empowers people to live positive, productive, and purposeful lives,” said Chief Executive Officer, Jared Turner. “Andrea is an accomplished marketing leader with an impressive track record of building powerful brands that connect with consumers, developing marketing tools that inspire and empower field leaders within the network marketing channel, and optimizing marketing teams to support sales field organizations. She will be charged with helping Amare deepen our brand identity and influence, and continue to amplify our mission, partnering with our global field leaders and markets to improve Brand Partner and Customer experience. Andrea is a passionate and purpose-driven leader who inspires everyone around her. I couldn’t be happier to have her powerful voice at the executive leadership table.”
Neipp brings over twenty years of marketing experience and business strategy to Amare and has worked with lifestyle and wellness brands including Oakley, adidas, Zarbee’s, Aveda, and Young Living. Her expertise includes developing brand positioning, generating awareness based on market insights, creating marketing tools for sales leaders, and strengthening relevancy for both emerging and well-known brands.
“I am inspired by the trailblazing, purpose-driven mental wellness mission of Amare and embrace the opportunity to shine an even greater light on the importance of destigmatizing and empowering the conversation around mental wellness, through innovative products backed by science and championing mindful practices that support resilience and deepen connection,” said Neipp. “Amare is a diverse community of professionals, entrepreneurs, and customers from all walks of life. We have an incredible team who is guided by the belief that everything and everyone is connected, and I look forward to furthering the reach of this message on an international scale.”
About Amare Global
Amare Global® (amare.com) is The Mental Wellness Company® and is the category leader in creating holistic mental wellness solutions. The name Amare translates “to love” in Latin and a core part of its mission is to create more love, empowerment, and wellness in the world by providing high-quality natural products that support holistic wellness. Amare’s patented and award-winning proprietary formulations leverage the powerful science of the gut microbiome and the gut-brain axis (GBX), along with other clinically studied ingredients and blends. For more information, visit Amare.com, follow @amareglobal on Instagram, or visit us on Facebook.
The study reflects 43 patients representing 69 total treated levels who received a CT scan at a mean of 459 days post-procedure. Fusion was assessed by three independent radiologists showing 93% of the assessed levels were fused.
There were also no instances of device migration, mechanical failures, or device related reoperations. The analysis from the radiologists demonstrated that Minuteman provides clinically meaningful fusion rates with a low risk of spinous process fracture or other device related complications.
“Thank you to Dr. Gabriel Jasper,Dr. Matthew Skoblar,Dr. Doug Bealland Dr. Tom Hedmanfor their significant contribution to this work. The purpose of this study was to evaluate lumbar spinal fusion outcomes in real-world patients instrumented with the Minuteman device,” said Adam Rogers, VP of Regulatory and Engineering. “We were able to show that patients receiving instrumented posterior arthrodesis of the lumbar spine using the Minuteman did indeed fuse at a rate comparable to other lumbar fusion constructs, and that the Minuteman performed very well mechanically with no intraoperative complications or device-related reoperations.”
About Spinal Simplicity, LLC
Spinal Simplicity, LLC, headquartered in Overland Park, Kansas, was founded in 2008 with a vision to be the global leader in innovation, simplified surgical solutions, delivering uncompromising quality. The company has successfully been awarded 150+ patents with additional patent applications pending. For more information visit spinalsimplicity.com or follow us on LinkedIn.
Michael B. Atkins, MD – Georgetown University’s Lombardi Comprehensive Cancer Center Nina Bhardwaj, MD, PhD – Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute Douglas R. Lowy, MD – National Cancer Institute, NIH Crystal Mackall, MD – Stanford University Miriam Merad, MD, PhD – Icahn School of Medicine at Mount Sinai Jeffrey S. Weber, MD, PhD – Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
SITC solicits nominations and inducts a new class of FAIO on an annual basis. The next call for nominations will be in the spring of 2024.
The Academy of Immuno-Oncology was established by SITC to honor individuals who have launched the field of cancer immunotherapy into the breakthrough cancer treatment it is today, bringing together the brightest minds in the field in order to inspire the next generation of immuno-oncologists.
About SITC Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on X, LinkedIn, Facebook, Instagram and YouTube.
HUMORISTS FOCUS ON THEIR BLESSINGS AND THE BRIGHT SIDE OF LIFE > 74% of Humorists said that they are able to find the silver lining in negative situations (vs. 34% of Non-humorists). > 69% make it a point to appreciate the little things in life (vs. 29% of Non-humorists). > 73% seek and find beauty all around them (vs. 20% of Non-humorists). > 72% actively adopt an attitude of gratitude (vs. 27% of Non-humorists).
HUMORISTS ARE PERSEVERANT AND MENTALLY TOUGH > 86% feel they have something to live for (vs. 56% of Non-humorists). > 70% believe that all obstacles are temporary (vs. 34% of Non-humorists). > 80% believe that all problems can be resolved or their impact diminished (vs. 42% of Non-humorists). > 61% believe that it is possible to completely overcome the negative impact of a traumatic experience (vs. 43% of Non-humorists). > 81% view hardship as an opportunity to learn, grow, and become stronger and wiser (vs. 46% of Non-humorists). > 62% push themselves to overcome their fears (vs. 31% of Non-humorists). > 71% are mostly or very satisfied with their jobs (vs. 52% of Non-humorists).
IN CONTRAST, PEOPLE WHO DON’T HAVE A STRONG SENSE OF HUMOR TEND TO STRUGGLE WITH MENTAL AND PHYSICAL HEALTH ISSUES: > 53% have a tendency to get upset over minor issues (vs. 30% of Humorists). > 65% often criticize or insult themselves (vs. 40% of Humorists). > 40% are chronic complainers (vs. 20% of Humorists). > 26% took more than five sick days in the last year due to illness (vs. 13% of Humorists). > 14% took more than five sick days in the last year due to stress (vs. 11% of Humorists).
“When you’re having a really bad day at work or are struggling in a relationship or with your health, you’re probably not going to be in the mood to laugh, but these are the times when laughter can be the most beneficial,” explains Dr. Ilona Jerabek, president of PsychTests. “Laughter releases endorphins, reduces emotional and physical tension, strengthens your immune system, and can completely shift your mood.”
And while some people might think that using humor is the same as being in denial, PsychTests data indicates that this is not necessarily the case.
“Our study found that nearly half of the humorist group, 47%, will allow themselves to fully feel their negative emotions rather than trying to ignore or suppress them, whereas only 32% of the Non-humorist group do this,” states Dr. Jerabek. “In addition, the people who use laughter to cope with stress also use other healthy coping strategies, including mindfulness, meditation, deep breathing, and channeling their emotions into something creative.”
So for people who are feeling the weight of the world on their shoulders, finding something funny to read or watch can be highly beneficial.
“It’s your choice: you can focus all of your attention on the negative side of life or look for the humorous side; either way, you’re just pushing your perception in a specific direction. All you need to do is switch your viewpoint, like redirecting a telescope towards a different location in the sky. It’s not about ignoring those unpleasant parts; you’re acknowledging that a blackhole of negativity exists; it’s just that you’re choosing to shift your gaze to some stars now. Although there is bad stuff going on in your life, there is likely at least a few good things too if you’re willing to look for them,” concludes Dr. Jerabek.
Professional users, such as HR managers, coaches, and therapists, can request a free demo for this or other assessments from ARCH Profile’s extensive battery: http://hrtests.archprofile.com/testdrive_gen_1
About PsychTests AIM Inc. PsychTests AIM Inc. originally appeared on the internet scene in 1996. Since its inception, it has become a pre-eminent provider of psychological assessment products and services to human resource personnel, therapists and coaches, academics, researchers and a host of other professionals around the world. PsychTests AIM Inc. staff is comprised of a dedicated team of psychologists, test developers, researchers, statisticians, writers, and artificial intelligence experts (see ARCHProfile.com).
With the health and wellness market now worth an estimated $1.5 Trillion, and demand soaring for wellness and nutrition products that provide health benefits, like prevention or better management of disease, in addition to their basic nutritional value, the scientific team at SignalChem Plantech developed this proprietary product by leveraging cellular agriculture techniques to meet that demand. Phyto-P™ is enriched with unprecedented levels of antioxidant polyphenols such as quercetin, along with compounds like chlorogenic acid, chicoric acid, and anthocyanins.
There are more than 500 different types of polyphenols and research shows these natural phytochemicals can help support your well-being and assist with the management of certain chronic conditions like cardiovascular disease, and diabetes. For these reasons and others, polyphenols are a popular choice amongst consumers and naturopathic doctors.
“Our research has shown that Phyto-P™ has immune boosting activity and is a natural powerhouse against the cytokine storm,” said SignalChem CEO Mr. Jun Yan, who developed this transformative breakthrough in managing the well-being of humanity. “We now have data with Phyto-P™ that clearly illustrates how the combined action of this polyphenol-rich game-changing solution produces a significantly greater impact than any individual polyphenol on its own.”
As little as one teaspoon a day of Phyto-P™ can provide a natural immune booster, with the power to reduce important cytokines known to drive inflammatory processes.
“Phyto-P™ is a breakthrough innovation in the health and wellness space. Enriched with higher levels of a variety of polyphenols, this product has the ability to combat inflammation, support gut health and act as a shield against pressures of modern life,” said Peqish’s CEO Dr. Marotta, PhD. ” Think of it as your body’s resilience boost, backed by solid science and regulatory approval. It’s not just a product; it’s a new era of well-being strengthened by leveraging the power of nature.”
Aegis also marked a major milestone in September 2022 when it received regulatory clearance from Canada’s Natural and Non-Prescription Health Products Directorate, NPN80121356. This is the entity responsible for authorizing natural health products and non-prescription drugs for sale in Canada, and ensuring they meet safety, efficacy, and quality standards.
“We are thrilled to partner with Peqish to leverage their deep clinical knowledge and product formulation expertise for this innovative phytochemical-rich ingredient,” said Aegis CEO Nicolas Zhang. “Imagine a world where we leverage the power of nature to help people. This breakthrough has tremendous potential to improve human health and we are excited to continue to build the scientific body of evidence to support its benefits.”
Peqish is currently seeking partnerships exclusively with businesses focused on producing and distributing specialty products for athletic performance and in the health and wellness sector. If you are interested in learning more about this exciting opportunity, please connect with us today by email: kto(at)peqish.com to explore how we can collaborate and drive better health outcomes for everyone. For more information on Phyto-P™, watch this brief presentation on the benefits of Phyto-P™ for athletic performance or visit our website for more details.
About Peqish Group, Food & Hospitality
Peqish Group is an ag-tech company that combines cutting-edge technology with deep scientific and clinical understanding to bring forth innovative solutions that support people’s well-being. We are committed to utilizing the latest advancements to develop products that have the potential to address and even possibly resolve disease. Our team of experts is dedicated to the pursuit of a healthier and more sustainable future for all, and we are proud to be at the forefront of this exciting and rapidly evolving industry. Whether it’s through our ground-breaking research or the development of new, innovative products, our mission is to help people achieve optimal health and wellness.
About Aegis
Aegis Biopharmaceuticals Inc, in collaboration with our parent company SignalChem, is committed to assisting individuals in upholding a harmonious immune system using entirely natural, non-toxic, and side-effect-free solutions that yield notable outcomes. With our latest research and development of natural polyphenol technology, we are committed to reducing chronic inflammation in the human body.
Our parent company, SignalChem, is a leader in the biotechnology industry specializing in the research and production of innovative and high-quality human recombinant cell signaling products. Together we are committed to creating effective research tools and supporting scientists from academic institutions, pharmaceutical companies, and biotechnology companies around the world, advancing basic research in life sciences and facilitating drug development. Phyto-P™ is a trademark managed by Aegis.
About SignalChem
SignalChem Plantech, a subsidiary of SignalChem Lifesciences Corp., is a biotechnology company dedicated to developing a wide range of plant-based solutions for human health with a particular focus on autoimmune and other immune-related diseases. The company is known for its unique approach to upregulating targeted secondary metabolites in plants, and for developing a highly efficient plant protein-expression platform. Over the years, SignalChem has used its core expertise in cell signaling, molecular biology, and protein biochemistry to produce more than 2,000 functional protein products.
Forward Looking Statements
Information set forth in this news release may involve forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company’s expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include but are not limited to the following risks: those associated with marketing and sale of securities; the need for additional financing; reliance on key personnel; the potential for conflicts of interest among certain officers or directors with certain other projects; and the volatility of common share price and volume. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and except as required by law, the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements.
Data-driven Patient Profiles: Use indication-specific, consumer behavior, and other real-world data sources to identify and understand ideal participants
Hyper-targeted Digital Recruitment: Create and deliver compelling materials in search, social, and programmatic channels to meet patients and families where they are in their journey
Medical Secondary Screening: Reduce site burden by providing only high-quality patient referrals with 2-step pre-qualification
Real-time Performance and ROI Results: Track patient journeys and uncover actionable insights in the Trialbee Honey Platform™, a vendor-agnostic single funnel to manage ROI of all recruitment sources
In addition, the urgent nature of rescue studies underscores the need for flexibility, hands-on project success management, and trusted collaboration. In response, Trialbee Rescue Kit enables our expert recruitment team to partner with customers in order to…
Analyze enrollment data across geographies and sites to overcome historical challenges
Optimize pre-screener and medical secondary screening tips to improve conversion rates and prevent inadvertent drop-outs or self-disqualification
Leverage our global team with multiple project managers working in different time zones to expedite document development, IRB review, and kickoff
Create campaign materials in advance to be prepared for immediate launch
Train and engage all site users to focus and supplement their efforts and activities
“A commonly cited and unfortunate statistic suggests that up to 80% of clinical trials will experience delays and additional cost due to patient recruitment shortcomings,” said Gaynor Anders, Chief Delivery Officer at Trialbee. “We created Rescue Kit to provide immediate and urgent assistance to studies in need of a boost without sacrificing any of the value that sets Trialbee apart in terms of our data-driven and hyper-targeted approach. Thanks to the unprecedented transparency of our Honey Platform, sponsors and study teams are able to see in granular detail what’s working, and what isn’t, across all your recruitment partners – so you can make decisions now that will improve the trajectory of your trial’s LPI goals.”
About Trialbee Trialbee is the leading global data and technology platform for patient recruitment and enrollment in clinical trials. Trialbee Hive™ operationalizes real-world data (RWD) and applies data science to find patients globally. Trialbee Honey™ simplifies the journey into clinical research for patients, reduces the burden of enrolling patients for sites, and provides real-time, data-driven insights to sponsors and CROs so they can optimize enrollment timelines. Partnering with sponsors, CROs, and virtual/decentralized sites and software providers, Trialbee is achieving patient enrollment goals and driving enhancements in diversity in clinical trial populations. We are the smartest way to match and enroll patients for your clinical trial. For more information, visit https://www.trialbee.com or contact us at [email protected]
A Marine Corps veteran and a graduate of the Wharton School at the University of Pennsylvania with a Master of Business Administration, Esterly’s ‘help one more’ ethos reflects his military background and dedication to exceeding expectations in serving others.
“Brian’s distinguished background is steeped in a profound commitment to service. His unwavering dedication to serving others and his comprehensive understanding of intricate healthcare landscapes have consistently set him apart,” said Mirza Baig, managing partner of Aldrich Capital Partners, TimeDoc Health’s lead investor. “He embodies a selfless approach to leadership that prioritizes patients, and the wide spectrum of healthcare needs they have. This positions the company to advance ambitiously, ensuring enhanced patient support at its core.”
During his tenure at Centria Healthcare, Esterly assumed accountability for both cultivating new client sales and nurturing existing client relationships, while upholding Centria’s mission of prioritizing patient well-being. Moreover, his development of a comprehensive go-to-market strategy enabled the company’s expansion into four new markets, solidifying Centria’s market-leading position.
Prior to this role, he served as the chief operating officer of Solera Health, a preventive care benefits manager. He worked in a similar capacity for Aspire Health, an in-home palliative care services provider. Both organizations experienced significant growth and improved patient experiences during his tenure.
“TimeDoc has a history of success, and I am deeply honored to be granted the opportunity to further enhance the accomplishments set in motion by the founding team, including Will Boeglin,” said Esterly. “I am excited about spearheading the organization’s journey during this period of growth, as we extend our services to an even greater number of patients.”
Co-founding the company in 2015, Boeglin’s contributions were instrumental in securing $48.5 million in growth capital for the company in early 2022. He is committed to facilitating a seamless transition while retaining his role on the board and within the organization.
“TimeDoc’s future centers around the expansion of our collaborations with medical providers at the forefront of care, enhancing patient health outcomes and achieving success in the transition to value-based care,” said Boeglin. “The board and I selected Brian because of his extensive experience in working with industry leading health services companies to deliver preventive care services for older adults and the chronically ill. Embracing a seasoned and mission-driven healthcare leader like Brian stands as a testament to our unwavering commitment to our clients and patients.”
Currently, TimeDoc Health services more than 100,000 Medicare and Medicaid patients through virtual care management. The company also has more than 140 clients across 37 states. By leveraging proven engagements and investing in an expanded team, TimeDoc Health hopes to significantly drive enrollment and explore new service lines to support patients in need.
About TimeDoc Health
TimeDoc Health, based in Chicago, Illinois, is a leader in virtual care management. The company enables providers to deliver truly continuous, comprehensive care by helping them establish care management programs for patients with chronic health conditions. The solution combines a care management SaaS platform with care coordination services for chronic care management, remote patient monitoring, and behavioral health integration. For more information, visit www.timedochealth.com.
Media Contact
James Coates, TimeDoc Health, 1 844-784-8362, [email protected], timedochealth.com
A critical part of the region’s public utility infrastructure, the original North Aurora pump station was built in the 1960s and due to increasingly frequent repairs and maintenance, was nearing the end of its service life. It was designed to collect and lift untreated sewage in a pressurized main from below the Fox River to the gravity North Aurora interceptor many feet in elevation above the influent sewer. It provided service to 8,000 residents of North Aurora and over 14,500 residents of Kane and DuPage counties.
Construction of the replacement North Aurora Pump Station was a $9.8 million project designed by Strand Associates, a national engineering firm specialized in civic infrastructure. The new 32 million-gallon per day drywell submersible pump station comprises force mains (approximately 45 feet of 36-inch-diameter and 75 feet of 24-inch-diameter) between the new pumping station and connection points with existing force mains, and approximately 275 feet of a 42-inch-diameter gravity sewer to lift sewage flows approximately 65 feet (20 m) from the Fox River inverted siphon chamber to the North Aurora gravity interception sewer.
“The construction included a three-level below-grade concrete structure that would be in operation 24/7, all year round,” adds Patrick O’Brien, Regional Sales Manager for Penetron USA. “The project engineer required a proven and durable solution to counter the threat of microbially induced corrosion (MIC) of the new concrete pump station.”
Less well-known than many other threats to concrete structures, MIC is a serious challenge that can rapidly compromise and disable the concrete structures of wastewater and sewage system infrastructure. The thiobacillus bacteria, also known as acid-producing bacteria found in sewage and septic environments, converts the hydrogen sulfide gas (H2S) into biogenic sulfuric acid (H2SO4). The presence of sulfuric acid on concrete surfaces can unleash highly localized and rapid corrosion processes that eat away the cement paste of the concrete matrix. This, in turn, quickly exposes the embedded reinforcement steel of underground concrete sewage systems to water, oxygen, CO2, and chlorides – resulting in catastrophic corrosion related failures in the concrete.
Penetron’s antimicrobial admixture prevents microbial-induced corrosion (MIC) by using an electro-physical mechanism to destroy the cell walls of the thiobacillus bacteria on contact. Eliminating the bacterial growth on and in concrete consistently stops the formation of biogenic sulfuric acid, avoiding the damage caused by MIC.
Narvick Brothers Ready Mix Concrete added Penetron’s antimicrobial admixture and crystalline waterproofing admixture, PENETRON ADMIX SB, to the concrete mix for all concrete elements of the pump station, connection points with existing force mains, and the final gravity sewer line. PENETRON ADMIX SB was added to the concrete to not only waterproof the concrete but also provide much needed reinforcing corrosion mitigation and increase the service life of the concrete by substantially slowing the aging of the concrete.
“Identical to the well-known PENETRON ADMIX, a crystalline concrete waterproofing admixture, the antimicrobial properties of this specialized admixture are permanent,” explains Patrick O’Brien. “Once added to the mix, it becomes a permanent part of the concrete matrix and is leach resistant, even repeated contact with bacteria can not lessen the effectiveness of the admixture.”
The Penetron Group is a leading manufacturer of specialty construction products for concrete waterproofing, concrete repairs, and floor preparation systems. The Group operates through a global network, offering support to the design and construction community through its regional offices, representatives, and distribution channels.
For more information on Penetron waterproofing solutions, please visit penetron(dot)com or Facebook(dot)com/ThePenetronGroup, email CRDept(at)penetron(dot)com or contact the Corporate Relations Department at 631-941-9700.
